Deciphering the Factors of Longevity Through a Multi-Omics Study in Long-Lived Individuals in Hong Kong

Recruiting Observational Study
Aging
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 and older
Sex
Any
Study type
Observational
Participants needed
2,500 (estimated)
Sponsor
Hong Kong University of Science and Technology · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Population aging is changing societal dynamics and poses significant global challenges. By 2050, an estimated 1.6 billion people worldwide will be over age 65. Because aging is the primary risk factor for many common chronic diseases, it is essential to reduce the burden of age-related illnesses and promote healthy aging. Hong Kong has one of the largest proportions of elderly adults and has the h…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Han Chinese ethnicity 2. Able to provide official evidence for being 95 years or older (e.g., a birth certificate) 3. Mentally capable of consenting to join the study with or without informant presence 4. Consent to donation of biospecimens (i.e., blood) Exclusion Criteria: …
Contacts

Nancy Ip, PhD

+852-23587304

boip@ust.hk

CONTACT

Hiu Yi Wong, PhD

+852-23587344

annawong@ust.hk

CONTACT